1. Home
  2. HCWB vs CISO Comparison

HCWB vs CISO Comparison

Compare HCWB & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$3.26

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.26

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
CISO
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
13.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HCWB
CISO
Price
$3.26
$0.26
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
61.4K
112.3K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.31
EPS
0.37
N/A
Revenue
$4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.21
52 Week High
$7.35
$1.48

Technical Indicators

Market Signals
Indicator
HCWB
CISO
Relative Strength Index (RSI) 52.15 46.77
Support Level $0.37 $0.24
Resistance Level $4.00 $0.32
Average True Range (ATR) 0.44 0.02
MACD -0.03 0.00
Stochastic Oscillator 50.53 54.11

Price Performance

Historical Comparison
HCWB
CISO

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

Share on Social Networks: